Axogen (AXGN) Return on Invested Capital (2012 - 2013)

Axogen's (AXGN) quarterly Return on Invested Capital came in at 0.07% in Q2 2013, up 161.27% quarter-over-quarter from 0.11% in Q4 2012.

Axogen (AXGN) Return on Invested Capital (2012 - 2013) Analysis & Trends

Axogen's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.07% for Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	0.01%
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	0.01%
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	0.01%
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	-
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	0.00%
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	0.00%
10	Axogen	2.12 Bn	2.02 Bn	46.19 Mn	-

Download Data